Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Texas Oncology, a 7,345-square foot investment property located in Cleburne, Texas, according to Joe Powers, regional manager of the firm’s Chicago Downtown office.

Alex Sacks, Brett Rodgers, Frank M. Roti, and Garret Wolfe investment specialists in Marcus & Millichap’s Chicago Downtown and Dallas office, had the exclusive listing to market the property on behalf of the seller, a private investor. The buyer, also a private investor , was secured by Alex Sacks, Brett Rodgers and Frank Roti. Tim Speck, Texas Broker of Record assisted in closing this transaction.

Texas Oncology is located at 191 Walls Dr in Cleburne, Texas. The subject property was built in 2001 and Texas Oncology has been operating at this location since 2009. The property benefitted from being on campus to the Texas Health Resources Hospital which is a 137-bed short-term acute care facility.

About Marcus & Millichap (NYSE: MMI)

With over 2,000 investment sales and financing professionals located throughout the United States and Canada, Marcus & Millichap is a leading specialist in commercial real estate investment sales, financing, research and advisory services. Founded in 1971, the firm closed 9,726 transactions in 2019 with a value of approximately $50 billion. Marcus & Millichap has perfected a powerful system for marketing properties that combines investment specialization, local market expertise, the industry’s most comprehensive research, state-of-the-art technology, and relationships with the largest pool of qualified investors. To learn more, please visit: www.MarcusMillichap.com.